Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Patient Response Trajectories in Major Depressive Disorder
1
x
$
30.00
Letter From the Editors: Are You Ready For Some Ethics, Some Success, Some Cytoprotectants, and Some New Board Members?
1
x
$
0.00
VOL 47 No. 3 Table of Contents
1
x
$
0.00
C. Philip O’Carroll, MD: Migraine And The Limbic System: Closing The Circle
1
x
$
30.00
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS)
1
x
$
0.00
Can a ‘Shot’ Help Prevent Youth Re-Incarceration? Case Report on Use of a Long-Acting Injectable Antipsychotic in Incarcerated Youth (OPEN ACCESS)
1
x
$
0.00
Diagnosis and Staging of Gynecological Malignancies
1
x
$
0.00
Psychopharmacology Bulletin VOL 46 No. 1 - Full Issue Stacked PDF
1
x
$
60.00
Pharmacy Practice: In Vitro Tests to Predict Human Tumor Sensitivity to Cytotoxic Agents
1
x
$
0.00
Pharmacy Practice: The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer: What Should Patients Be Told?
1
x
$
0.00
Efficacy of Electrical Spinal Cord Stimulation with Neuromodulating Medications: A Systematic Review
1
x
$
30.00
Influence of CYP2C19*17 Genetic Polymorphism on the Steady-State Concentration of Escitalopram in Patients with Recurrent Depressive Disorder
1
x
$
30.00
View Cart
Checkout
Home
Store
“Influence of CYP2C19*17 Genetic Polymorphism on the Steady-State Concentration of Escitalopram in Patients with Recurrent Depressive Disorder” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Raising the Expectations of Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Jeffrey Alderman, PhD: The Effect of Food on the Absorption of Oral Ziprasidone
$
30.00
Add to cart
Details
Raising the Expectations of Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Can We Distinguish Anxiety From Depression?
$
30.00
Add to cart
Details
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
$
30.00
Add to cart
Details
Algorithms in Clinical Psychiatry: A Stepped Approach Toward the Path to Recovery
$
30.00
Add to cart
Details
Depression Treatment: A Lifelong Commitment?
$
30.00
Add to cart
Details
Mechanism of Action of Antidepressants
$
30.00
Add to cart
Details
Depression in the Elderly
$
30.00
Add to cart
Details
Coping With Somatic Comorbidities: Striving for Complete Recovery
$
30.00
Add to cart
Details
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Generalized Anxiety Disorder: Raising the Expectations of Treatment
$
30.00
Add to cart
Details
New Developments in the Neurobiological Basis of Anxiety Disorders
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Affective Disorders
$
30.00
Add to cart
Details
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
$
30.00
Add to cart
Details
Recent Advances in the Neurobiology of Depression
$
30.00
Add to cart
Details
Remission: Today’s Target in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Comparing the Methods Used to Compare Antidepressants
$
30.00
Add to cart
Details
Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
$
30.00
Add to cart
Details
Previous
1
…
38
39
40
…
44
Next
Page load link
Go to Top
